{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:23:28Z","timestamp":1794713008109,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T00:00:00Z","timestamp":1541980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Internal funding","award":["Linea D1:2013-2018"],"award-info":[{"award-number":["Linea D1:2013-2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Headache Pain"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s10194-018-0940-5","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T07:10:39Z","timestamp":1542006639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Perampanel inhibits calcitonin gene-related peptide release from rat brainstem in vitro"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1030-9429","authenticated-orcid":false,"given":"Giuseppe","family":"Tringali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Curr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Navarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"940_CR1","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrneurol.2012.222","volume":"8","author":"W L\u00f6scher","year":"2012","unstructured":"L\u00f6scher W, Schmidt D (2012) Epilepsy: perampanel - new promise for refractory epilepsy? Nat Rev Neurol 8:661\u2013662","journal-title":"Nat Rev Neurol"},{"key":"940_CR2","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1111\/j.1528-1167.2011.03109.x","volume":"52","author":"T Hanada","year":"2011","unstructured":"Hanada T, Hashizume Y, Tokuhara N, Takenaka O, Kohmura N, Ogasawara A, Hatakeyama S, Ohgoh M, Ueno M, Nishizawa Y (2011) Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 52:1331\u20131340","journal-title":"Epilepsia"},{"key":"940_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1212\/WNL.0b013e3182635735","volume":"79","author":"JA French","year":"2012","unstructured":"French JA, Krauss GL, Biton V, Squillacote D, Yang H, Laurenza A, Kumar D, Rogawski MA (2012) Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304. Neurology 79:589\u2013596","journal-title":"Neurology"},{"key":"940_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1528-1167.2012.03638.x","volume":"54","author":"JA French","year":"2013","unstructured":"French JA, Krauss GL, Steinhoff BJ, Squillacote D, Yang H, Kumar D, Laurenza A (2013) Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305. Epilepsia 54:117\u2013125","journal-title":"Epilepsia"},{"key":"940_CR5","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1212\/WNL.0b013e318254473a","volume":"78","author":"GL Krauss","year":"2012","unstructured":"Krauss GL, Serratosa JM, Villanueva V, Endziniene M, Hong Z, French J, Yang H, Squillacote D, Edwards HB, Zhu J, Laurenza A (2012) Randomized phase III study 306: adjunctive perampanel for refractory partial-onset seizures. Neurology 78:1408\u20131415","journal-title":"Neurology"},{"key":"940_CR6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/epi.12643","volume":"55","author":"GL Krauss","year":"2014","unstructured":"Krauss GL, Perucca E, Ben-Menachem E, Kwan P, Shih JJ, Cl\u00e9ment JF, Wang X, Bagul M, Gee M, Zhu J, Squillacote D (2014) Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307. Epilepsia 55:1058\u20131068","journal-title":"Epilepsia"},{"key":"940_CR7","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","volume":"85","author":"JA French","year":"2015","unstructured":"French JA, Krauss GL, Wechsler RT, Wang XF, DiVentura B, Brandt C, Trinka E, O'Brien TJ, Laurenza A, Patten A, Bibbiani F (2015) Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy. A randomized trial. Neurology 85:950\u2013957","journal-title":"Neurology"},{"key":"940_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/head.12536","volume":"55","author":"BL Nye","year":"2015","unstructured":"Nye BL, Thadani VM (2015) Migraine and epilepsy: review of the literature. Headache 55:359\u2013580","journal-title":"Headache"},{"key":"940_CR9","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s40265-014-0262-0","volume":"74","author":"K Chan","year":"2014","unstructured":"Chan K, VanDenBrink A (2014) Glutamate receptor antagonists in the management of migraine. Drugs 74:1165\u20131176","journal-title":"Drugs"},{"key":"940_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/BF01046588","volume":"23","author":"MA Kai-Kai","year":"1991","unstructured":"Kai-Kai MA, Howe R (1991) Glutamate-immunoreactivity in the trigeminal and dorsal root ganglia, and inter-spinal neurons and fibres in the dorsal horn of the rat. Histochem J 23:171\u2013179","journal-title":"Histochem J"},{"key":"940_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0304-3940(92)90339-9","volume":"141","author":"SJ Tallaksen-Greene","year":"1992","unstructured":"Tallaksen-Greene SJ, Young AB, Penney JB, Beitz AJ (1992) Excitatory aminoacid binding sites in the trigeminal principal sensory and spinal trigeminal nuclei of the rat. Neurosci Lett 141:79\u201383","journal-title":"Neurosci Lett"},{"key":"940_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1113\/jphysiol.1982.sp014220","volume":"327","author":"RG Hill","year":"1982","unstructured":"Hill RG, Salt TE (1982) An ionophoretic study of the responses of rat caudal trigeminal nucleus neurons to non-noxious mechanical sensory stimuli. J Physiol 327:65\u201378","journal-title":"J Physiol"},{"key":"940_CR13","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/j.1468-2982.2004.00723.x","volume":"24","author":"CN Sang","year":"2004","unstructured":"Sang CN, Ramadan NM, Wallihan RG, Chappell AS, Freitag FG, Smith TR, Silberstein SD, Johnson KW, Phebus LA, Bleakman D, Ornstein PL, Arnold B, Tepper SJ, Vandenhende F (2004) LY293558, a novel AMPA\/GluR5 antagonist, is efficacious and well-tolerated in acute migraine. Cephalalgia 24:596\u2013602","journal-title":"Cephalalgia"},{"key":"940_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/0333102413499648","volume":"34","author":"B Gomez-Mancilla","year":"2014","unstructured":"Gomez-Mancilla B, Brand R, J\u00fcrgens TP, G\u00f6bel H, Sommer C, Straube A, Evers S, Sommer M, Campos V, Kalkman HO, Hariry S, Pezous N, Johns D, Diener HC (2014) BGG492 Study Group. Randomized, multicenter trial to assess the efficacy, safety and tolerability of a single dose of a novel AMPA receptor antagonist BGG492 for the treatment of acute migraine attacks. Cephalalgia 34:103\u2013113","journal-title":"Cephalalgia"},{"issue":"Suppl 1","key":"940_CR15","first-page":"7","volume":"29","author":"PJ Goadsby","year":"2009","unstructured":"Goadsby PJ, Keywood C (2009) Investigation of the role of mGluR5 inhibition in migraine: a proof of concept study of ADX10059 in acute migraine treatment. Cephalalgia 29(Suppl 1):7","journal-title":"Cephalalgia"},{"key":"940_CR16","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pharmthera.2009.09.003","volume":"124","author":"CM Villal\u00f3n","year":"2009","unstructured":"Villal\u00f3n CM, Olesen J (2009) The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther 124:309\u2013323","journal-title":"Pharmacol Ther"},{"key":"940_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.neulet.2011.11.039","volume":"506","author":"G Tringali","year":"2012","unstructured":"Tringali G, Greco MC, Capuano A, Guerriero G, Curr\u00f2 D, Navarra P (2012) Flupirtine inhibits calcitonin-gene related peptide release from rat brainstem in vitro. Neurosci Lett 506:332\u2013335","journal-title":"Neurosci Lett"},{"key":"940_CR18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.peptides.2014.03.009","volume":"56","author":"MC Greco","year":"2014","unstructured":"Greco MC, Lisi L, Curr\u00f2 D, Navarra P, Tringali G (2014) Tapentadol inhibits calcitonin gene-related peptide release from rat brainstem in vitro. Peptides 56:8\u201313","journal-title":"Peptides"},{"key":"940_CR19","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/ejp.820","volume":"20","author":"MC Greco","year":"2016","unstructured":"Greco MC, Capuano A, Navarra P, Tringali G (2016) Lacosamide inhibits calcitonin gene-related peptide production and release at trigeminal level in the rat. Eur J Pain 20:959\u2013966","journal-title":"Eur J Pain"},{"key":"940_CR20","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.peptides.2010.09.018","volume":"32","author":"A Capuano","year":"2011","unstructured":"Capuano A, Curr\u00f2 D, Navarra P, Tringali G (2011) Cortistatin modulates calcitonin gene-related peptide release from neuronal tissues of rat. Comparison with somatostatin. Peptides 32:138\u2013143","journal-title":"Peptides"},{"key":"940_CR21","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.1468-2982.2007.01354.x","volume":"27","author":"A Capuano","year":"2007","unstructured":"Capuano A, Curr\u00f2 D, Dello Russo C, Tringali G, Pozzoli G, Di Trapani G, Navarra P (2007) Nociceptin (1-13) NH2 inhibits stimulated calcitonin-gene-related-peptide release from primary cultures of rat trigeminal ganglia neurones. Cephalalgia 27:868\u2013876","journal-title":"Cephalalgia"},{"key":"940_CR22","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.lfs.2015.12.032","volume":"145","author":"MC Greco","year":"2016","unstructured":"Greco MC, Navarra P, Tringali G (2016) The analgesic agent tapentadol inhibits calcitonin gene-related peptide release from isolated rat brainstem via a serotonergic mechanism. Life Sci 145:161\u2013165","journal-title":"Life Sci"},{"key":"940_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0304-3940(99)00810-1","volume":"276","author":"R Lingamaneni","year":"1999","unstructured":"Lingamaneni R, Hemmings HC (1999) Effects of anticonvulsivants on veratridine- and KCl-evoked glutamate release from rat cortical synaptosomes. Neurosci Lett 276:127\u2013130","journal-title":"Neurosci Lett"},{"key":"940_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.biopha.2017.07.137","volume":"94","author":"RK Khangura","year":"2017","unstructured":"Khangura RK, Bali A, Kaur G, Singh N, Jaggi AS (2017) Neuropathic pain attenuating effects of perampanel in an experimental model of chronic constriction injury in rats. Biomed Pharmacother 94:557\u2013563","journal-title":"Biomed Pharmacother"},{"key":"940_CR25","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/epi.12865","volume":"56","author":"PN Patsalos","year":"2015","unstructured":"Patsalos PN (2015) The clinical pharmacology profile of the new antiepileptic drug perampanel: a novel noncompetitive AMPA receptor antagonist. Epilepsia 56:12\u201327","journal-title":"Epilepsia"},{"key":"940_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11940-017-0463-4","volume":"19","author":"AR Tso","year":"2017","unstructured":"Tso AR, Goadsby PJ (2017) Anti-CGRP monoclonal antibodies: the next era of migraine prevention? Curr Treat Options Neurol 19:27","journal-title":"Curr Treat Options Neurol"}],"container-title":["The Journal of Headache and Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-018-0940-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s10194-018-0940-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s10194-018-0940-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T19:04:22Z","timestamp":1573499062000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejournalofheadacheandpain.biomedcentral.com\/articles\/10.1186\/s10194-018-0940-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["940"],"URL":"https:\/\/doi.org\/10.1186\/s10194-018-0940-5","relation":{},"ISSN":["1129-2369","1129-2377"],"issn-type":[{"value":"1129-2369","type":"print"},{"value":"1129-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,12]]},"assertion":[{"value":"14 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The animal study protocol was approved by the Italian Ministry of Health (licensed authorization to P. Navarra n.648\/2017-PR).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"107"}}